Background and aims: D-dimer is a marker of active fibrinolysis. Understanding how age-related factors affect D-dimer levels may help the interpretation of high D-dimer levels in older individuals. Methods: 776 Baltimore Longitudinal Study on Aging (BLSA) participants (mean age 68.4±13.9 yrs) were divided into three groups according to baseline D-dimer levels >200 ng/mL; 100-200 ng/mL and <100 ng/mL. Results: D-dimer level increased with age (p<0.0001). Using polychotomous logistic regression models, we found that age, cholesterol, triglycerides, creatinine, erythrocyte sedimentation rate, hemoglobin and body mass index were independently associated with D-dimer level. Conclusions: Rising levels of D-dimer with age can be explained in part by the high prevalence of pro-inflammatory conditions and increasing burden of lipid abnormalities, anemia and obesity. These factors compromise the specificity of D-dimer levels as a diagnostic aid to thrombosis in older individuals. (Aging Clin Exp Res 2010; 22: 20-23) 
of factors that affect D-dimer levels in old age may improve the clinical interpretation of elevated levels. In addition, understanding factors that affect D-dimer levels may be important to start developing age-specific values of Ddimer above which more in depth testing should be performed.
We hypothesize that elevated D-dimer levels in older people may be due to an increased rate of clot formation and fibrinolysis possibly activated by a systemic pro-inflammatory state, lipid abnormalities and obesity.
SUBJECTS AND METHODS

Study population
The Baltimore Longitudinal Study on Aging (BLSA) is a longitudinal rolling cohort study of the National Institute on Aging, initiated more than 49 years ago. A general description of the BLSA trial has been previously reported (6). Healthy volunteers aged 20 and older are enrolled in the study and participate in follow-up assessment visits approximately every 2 years; participants older than 80 years are evaluated yearly. Currently, the study population has about 1400 active participants. An independent institutional review board approved the BLSA study protocol, and participants provided informed consent. There were 776 participants, 388 female and 388 male, who had D-dimer values available for this analysis.
Methods
Blood samples were collected in the morning after the subjects had fasted for 12h. Laboratory assays performed at the time of participant visit at the Clinical Research Unit of the National Institute on Aging, included white blood count, MCV, LDH, reticulocyte, total cholesterol, total triglycerides, albumin, erythrocyte sedimentation rate (ESR), and other selected serum chemistries (creatinine, hemoglobin, iron, ferritin, folate levels, and homocysteine) which were all assayed by standard clinical methods. D-dimer was measured in our clinical laboratory INTRODUCTION D-dimer is one of the most commonly used clinical assays for the detection of active coagulation and in vivo fibrin formation and lysis. The D-dimer assay is widely used in clinical practice to rule out clinically suspected deep venous thrombosis and pulmonary embolism. In fact, a number of studies have demonstrated that normal Ddimer levels have a high negative predictive value for these medical conditions (1). The predictive value of Ddimer for thrombosis has been studied mostly in clinical populations or in patients who were at high risk of thrombosis based on clinical characteristics. The frequency of abnormally elevated D-dimer levels is higher in older individuals (2-5) even in the absence of detectable thrombosis; therefore, the specificity of elevated D-dimer in thrombosis declines with age. 
Correlates of D-dimer in older persons
Aging Clin Exp Res, Vol. 22, No. 1 21 using a fully automated, benchtop coagulation workstation with STA-Compact (Diagnostica Stago, Inc.) and levels are reported in nanograms per milliliter. Anthropometric measurements, including weight, height, and blood pressure (BP), were recorded at the time of the visit, body mass index was calculated as weight (kilograms)/(height [meters]) 2 using objectively assessed measures. Cigarette smoking history was assessed by self-report and coded as ever smoked vs never smoked. Physical activity was assessed by self-report of average time spent per week in 97 activities (7). BLSA participants completed a comprehensive health survey questionnaire at each visit, and all newly reported diagnoses were adjudicated by a nurse practitioner based on information from multiple sources including medical records and communication with the primary care physician.
Statistical analysis
Statistical analyses were performed using the SAS statistical package 9.1 (SAS Institute, Inc, Cary, NC). D-dimer levels were divided into three groups: group 1= D-dimer >200 ng/mL, group 2= 100-200 ng/mL and group 3= <100 ng/mL. In our laboratory, values of D-dimer above 200 ng/mL are considered abnormal.
The intermediate group was introduced in the analysis to test the hypothesis that inflammation and other age related factors may affect D-dimer levels even within the usual range. Different variables describing the D-dimer group were formally tested with analysis of variance for continuous variables and chi square test for categorical variables. Factors aside from age and sex that were independently correlated with D-dimer with a p-value <0.3 were entered into a polychotomous logistic regression model (CATMOD) predicting D-dimer group.
RESULTS
A total of 776 consecutive participants (mean age 68.4±13.9 yrs), 388 female and 388 male, with Ddimer measurements were used in these analyses. The characteristics of study participants according to D-dimer group are shown in Table 1 . The proportion of women was similar in the three study groups (group 1= D-dimer >200 ng/mL, group 2= 100-200 ng/mL and group 3= <100 ng/mL) with 50.2%, 54.5% and 46.7% respectively (Table 1) . D-dimer levels increased with age (p<0.0001) and were slightly higher in men than in women (Fig. 1) Values represent % (n) or mean ± SD (n), where n is the total number of subjects in the respective categories. 1 p-values from basic model; 2 p-values from analysis of covariance adjusted for age and sex. *Note that the distribution of physical activity, creatine kinase, white blood cell, reticulocytes, myocardial infarction, diabetes, cancer, angina, stroke, transitory ischemic attack, atrial fibrilation, congestive heart failure, chronic renal insufficiency, hypertension, rheumatic arthritis and osteoarthritis, were substantially similar between groups (adjusted p-value >0.3) and therefore they are not represented in this table. di L L and a g gro ro .5% and and 46 46.7% .7% r r er levels e incr increased eased with with ag re re sl sligh ig tly ly h high igher er in men m tha g. 1). Af fter ter adjus adjusti tin ng g for f a globin, to tot tal al chol les ester terol ol, BMI 
